Read Frequently Asked Questions
Microbiological Risk: Do I Really Need to Test Raw Materials for Microorganisms
This webinar will cover the regulatory perspective in testing raw materials for microorganisms and how you can manage the risk of raw materials being the major source of microbial contamination in your medical product manufacturing process.
Why Should You Attend:
Raw materials are often the major source of microbial contamination that is introduced into the manufacturing process. Raw materials of natural origin, such as animal and plant source, support an extensive and varied microflora. Some of these pose a risk to the product and patient.
This webinar will address the regulatory and industry viewpoints on the subject of testing raw materials for microorganisms. Each organization, as part of its risk management program, should assess the hazard that the raw materials pose to its products and manufacturing processes. Ultimately, the focus should be on patient safety and not just a regulatory requirement.
Attendees will learn how to assess the risk between reliance on your processes to remove microbial contaminants and the risk of potential recalls and/or patient welfare. You will learn how to effectively manage the risk of contamination from raw materials.
Areas Covered in the Webinar:
- What is a raw material?
- Regulatory perspective
- Industry view
- Consequences of contamination
- Risk management
Who Will Benefit:
This training webinar has been designed for the following personnel in pharmaceutical, biopharmaceutical and food manufacturing companies:
- Quality assurance personnel
- Quality control personnel
- Microbiology professionals
- Regulatory and compliance management
- Senior management
- Testing and validation professionals
Henry Urbach, is the founder of GMP Training, Development and Consulting, GMP TDC LLC, a New York-based consulting organization serving the life sciences industries. He has over 20 years of life sciences experience having held positions of increased responsibility in GMP training and QC microbiology. His experience includes managing and implementing CGMP compliance and quality systems training for major pharmaceutical and biotechnology organizations. He is a dynamic speaker specializing in FDA and ICH compliance. He is a certified quality auditor. His technical education is further complemented by his BA degree in biology and MBA, which provide both a scientific and business insight. He is a member of the ASTD, ASQ, and GMP TEA, a national organization of life sciences training professionals.
In order to reduce cost of production, many organizations are re-examining the need for testing raw materials. Many manufacturing processes provide a hostile environment for the growth of microorganisms and low risk of microbial contamination. This is true of raw materials that are chemical synthesized. The same cannot be said of those materials that are sourced from natural materials. Moreover, some microorganisms survive even in the harshest environments. Each organization must assess the risk between reliance on its processes to remove microbial contaminants and the risk of potential recalls and/or patient welfare.
Some of the microorganisms in raw materials pose a risk to product and the patient. That is why regulators from around the world have established bioburden limits, and call for absence of certain microorganisms, such E. coli, Pseudomonas spp., and Salmonella. The presence of certain microorganisms does not only pose threat to the patient in terms of health, but it also causes product spoilage. Through their natural degradative capabilities, they cause deterioration of pharmaceuticals.
ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.
Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.
If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.
We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email firstname.lastname@example.org or call +1-888-717-2436(Toll Free).
This training hasn't been reviewed yet.
Auditing for Microbiological Aspects of Pharmaceutical and Biopharmaceutical Manufacturing You Found an Objectionable Microorganism, Now What? Risk of presence of Objectionable Microorganisms in Biopharmaceuticals Creating Effective SOPs for Regulatory Compliance Why I should test raw materials for microbial presence and what is the microbiological and business risk if I choose not to?